ARCHIVES

Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 8 | August 27, 2010

Download PDF Visit The Full Archive

Related Articles

FDA Gives Accelerated Approval To Tykerb For Metastatic Breast Cancer

February 5, 2010

At Its Launch, STAR Trial Inherits Baggage Of Its Predecessor, P-1 Tamoxifin Study

June 4, 1999

Intramural Funding To Decrease, R01s Increase, Klausner Says

September 15, 1995

Cancer Meetings Listed

April 15, 1994

Georgetown Sponsors Oncology Agent Development Meeting

February 21, 2003

First Mobil NMR Scanner Goes Into Operation At Temple

June 22, 1984